Literature DB >> 17098482

Endocytic trafficking of CFTR in health and disease.

Nadia Ameen1, Mark Silvis, Neil A Bradbury.   

Abstract

The cystic fibrosis transmembrane conductance regulator (CFTR) is a Cl-selective anion channel expressed in epithelial tissues. Mutations in CFTR lead to the genetic disease cystic fibrosis (CF). Within each epithelial cell, CFTR interacts with a large number of transient macromolecular complexes, many of which are involved in the trafficking and targeting of CFTR. Understanding how these complexes regulate the trafficking and fate of CFTR, provides a singular insight not only into the patho-physiology of cystic fibrosis, but also provides potential drug targets to help cure this debilitating disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17098482      PMCID: PMC1964799          DOI: 10.1016/j.jcf.2006.09.002

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  126 in total

1.  Targeting of membrane proteins to endosomes and lysosomes.

Authors:  I V Sandoval; O Bakke
Journal:  Trends Cell Biol       Date:  1994-08       Impact factor: 20.808

Review 2.  Unconventional myosins in cell movement, membrane traffic, and signal transduction.

Authors:  V Mermall; P L Post; M S Mooseker
Journal:  Science       Date:  1998-01-23       Impact factor: 47.728

Review 3.  Signal-dependent membrane protein trafficking in the endocytic pathway.

Authors:  I S Trowbridge; J F Collawn; C R Hopkins
Journal:  Annu Rev Cell Biol       Date:  1993

4.  Functional analysis of the C-terminal boundary of the second nucleotide binding domain of the cystic fibrosis transmembrane conductance regulator and structural implications.

Authors:  Martina Gentzsch; Andrei Aleksandrov; Luba Aleksandrov; John R Riordan
Journal:  Biochem J       Date:  2002-09-01       Impact factor: 3.857

5.  Recycling of the insulin-sensitive glucose transporter GLUT4. Access of surface internalized GLUT4 molecules to the perinuclear storage compartment is mediated by the Phe5-Gln6-Gln7-Ile8 motif.

Authors:  S Palacios; V Lalioti; S Martinez-Arca; S Chattopadhyay; I V Sandoval
Journal:  J Biol Chem       Date:  2000-10-12       Impact factor: 5.157

6.  Rab11 regulates recycling through the pericentriolar recycling endosome.

Authors:  O Ullrich; S Reinsch; S Urbé; M Zerial; R G Parton
Journal:  J Cell Biol       Date:  1996-11       Impact factor: 10.539

Review 7.  [Early bronchial inflammation in cystic fibrosis].

Authors:  Edith Puchelle
Journal:  J Soc Biol       Date:  2002

Review 8.  Intracellular CFTR: localization and function.

Authors:  N A Bradbury
Journal:  Physiol Rev       Date:  1999-01       Impact factor: 37.312

9.  Biochemical and biophysical identification of cystic fibrosis transmembrane conductance regulator chloride channels as components of endocytic clathrin-coated vesicles.

Authors:  N A Bradbury; J A Cohn; C J Venglarik; R J Bridges
Journal:  J Biol Chem       Date:  1994-03-18       Impact factor: 5.157

10.  Regulation of cystic fibrosis transmembrane conductance regulator single-channel gating by bivalent PDZ-domain-mediated interaction.

Authors:  V Raghuram; D O Mak; J K Foskett
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-23       Impact factor: 11.205

View more
  46 in total

1.  Physiological relevance of cell-specific distribution patterns of CFTR, NKCC1, NBCe1, and NHE3 along the crypt-villus axis in the intestine.

Authors:  Robert L Jakab; Anne M Collaco; Nadia A Ameen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-10-28       Impact factor: 4.052

2.  Abnormal Rab11-Rab8-vesicles cluster in enterocytes of patients with microvillus inclusion disease.

Authors:  Georg F Vogel; Andreas R Janecke; Iris M Krainer; Karin Gutleben; Barbara Witting; Sally G Mitton; Sahar Mansour; Antje Ballauff; Joseph T Roland; Amy C Engevik; Ernest Cutz; Thomas Müller; James R Goldenring; Lukas A Huber; Michael W Hess
Journal:  Traffic       Date:  2017-05-17       Impact factor: 6.215

Review 3.  Trafficking Ion Transporters to the Apical Membrane of Polarized Intestinal Enterocytes.

Authors:  Amy Christine Engevik; James R Goldenring
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-01-02       Impact factor: 10.005

4.  Biochemical basis of the interaction between cystic fibrosis transmembrane conductance regulator and immunoglobulin-like repeats of filamin.

Authors:  Laura Smith; Richard C Page; Zhen Xu; Ekta Kohli; Paul Litman; Jay C Nix; Sujay S Ithychanda; Jianmin Liu; Jun Qin; Saurav Misra; Carole M Liedtke
Journal:  J Biol Chem       Date:  2010-03-29       Impact factor: 5.157

5.  Modulation of endocytic trafficking and apical stability of CFTR in primary human airway epithelial cultures.

Authors:  Deborah M Cholon; Wanda K O'Neal; Scott H Randell; John R Riordan; Martina Gentzsch
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-12-11       Impact factor: 5.464

6.  Protein kinase A modulates the activity of a major human isoform of ABCG1.

Authors:  Ingrid C Gelissen; Laura J Sharpe; Cecilia Sandoval; Geetha Rao; Maaike Kockx; Leonard Kritharides; Wendy Jessup; Andrew J Brown
Journal:  J Lipid Res       Date:  2012-08-07       Impact factor: 5.922

Review 7.  Optimized approaches for quantification of drug transporters in tissues and cells by MRM proteomics.

Authors:  Bhagwat Prasad; Jashvant D Unadkat
Journal:  AAPS J       Date:  2014-04-22       Impact factor: 4.009

8.  AP2 α modulates cystic fibrosis transmembrane conductance regulator function in the human intestine.

Authors:  Vandana Kumari; Shruti Desai; Nadia A Ameen
Journal:  J Cyst Fibros       Date:  2017-04-21       Impact factor: 5.482

9.  Cystic Fibrosis: The Mechanisms of Pathogenesis of an Inherited Lung Disorder.

Authors:  Mark T Clunes; Richard C Boucher
Journal:  Drug Discov Today Dis Mech       Date:  2007

10.  The L441P mutation of cystic fibrosis transmembrane conductance regulator and its molecular pathogenic mechanisms in a Korean patient with cystic fibrosis.

Authors:  Heon Yung Gee; Chang Keun Kim; So Won Kim; Ji Hyun Lee; Jeong-Ho Kim; Kyung Hwan Kim; Min Goo Lee
Journal:  J Korean Med Sci       Date:  2009-12-26       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.